
Capital Raising
COMPLETED
Oscar Resources Limited
Iron Ore company utilising breakthrough technology
INDUSTRY
Medical, Technology
RAISING
A$1.116M
PRE-MONEY VALUATION
A$8.9M
OFFER PRICE
A$0.171
Investment Highlights
Company Overview
Products & Services
Additional Information
Team
Transaction Summary

Biosignals Diagnostics
Raising A$1.116M
A$0.171 per share
Investment Highlights
Biosignal monitoring company
Prevent, diagnose, and change outcomes for heart disease & stroke
ECGme device provides cost effective & real time solutions
Precision Healthcare
Company Overview
Products & Services
Biosignals Diagnostics offers solutions that target unmet clinical needs or improved standard of care in heart disease, with verified customers and markets.
Biosignals Diagnostics is a biosignal monitoring company, that addresses heart disease problems by integrating biometric data from specially designed, easily used devices and other sources such as imaging and genetics.
Product Suite


ECGME
- Small easy to use the device (the size of a credit card), fits in your pocket and when held with fingers on the sensors analyses real-time ECG signals
- Point-in-time ECG snapshot configurable for up to 10 minutes monitoring duration
- Converts to a 2 electrode 24hr on-body monitor for clinical use
- A TGA-approved Class 2a medical device
- Available July 2022
Team
Management
Hayden Pitout
Chief Technical Officer
Kevin Hollingsworth
Company Secretary
Lexie Qin
Head of Product Engineering
Renee Ge
AI & Data Sciences Engineering
Stephan G Foy – MB ChB MD
Consulting Cardiologist & Clinical Advisor
Want to learn more?
Fill in the expression of interest form below